Decrease in J&J vaccine supply will impact distribution nationwide

Texas will see next week's Johnson & Johnson doses dropped to 130,000 from 500,000. So, what will a nationwide drop mean for the city?

Video Transcript

- The company that manufactures the Johnson & Johnson COVID-19 vaccine will be undergoing inspections by the FDA at its independent manufacturing plant this coming week after the plant has been battling issues, including what the company called a human error that forced them to throw out about 15 million doses last Saturday.

It's still unclear when the company will get the green light from the FDA to ramp up its production again. This means the supply of the one dose COVID-19 vaccine will be relatively low until further notice. The Texas Department of State health services reported it has already seen a major decrease in the J&J allocated doses, going from 500,000 doses this week to 130,000 next week.

SYLVESTER TURNER: We're not anticipating any sort of impact for this coming week.

- Houston Mayor Sylvester Turner, who was visiting one of the health department's COVID-19 vaccine sites today, says the city and the federally run NRG site have not seen the negative impacts from the J&J production issues.

SYLVESTER TURNER: NRG, for example they're doing the J&J, they have already gotten their supply for this week, so we're not expecting any negative impact from the 15 million doses that had to be thrown away from the J&J, so for this coming week, we ought to be fine. It may slow down, in, I say, the next week or two or three, in the ramp up phase, but in terms of people who have been scheduled, or the number that we had already planned, those numbers will be able to meet our targets for this coming week. But for us, the primary doses for our area have been the Pfizer and the Moderna.